Banco Santander SA vs GeneDx Holdings Corp — how do they compare? Banco Santander SA trades at $13.74 (market cap $191.46B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Banco Santander SA is far larger — about 106.4× GeneDx Holdings Corp's market cap, and Banco Santander SA pays a 2.09% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| SAN | WGS | |
|---|---|---|
Market Cap | $191.46B | $1.80B |
Sector | Financials | Technology |
52-Week High | $14.37 | $167.51 |
52-Week Low | $8.40 | $34.51 |
Dividend Yield | 2.09% | — |
Enterprise Value | — | $1.80B |
Trailing returns across standard periods
Santander's focus is on retail and commercial banking. Latin America is geographically the largest operation, with Brazil by far the largest. Its continental European business is still mainly Iberian. Santander's U.K. presence is the result of the acquisition of building society Abbey. In the U.S., Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.
Read more on SAN →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →